Befejeződött1. fázis
A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy
Key facts
- Where
- Essen, Hamburg, Heidelberg és Munich, NémetországSee the 4 sites
- Phase
- 1. fázis
Where in Németország
- Universitaetsklinikum Essen (AoR)Essen, NémetországNo longer taking part
- University Medical Center Hamburg-EppendorfHamburg, NémetországNo longer taking part
- Universitaetsklinikum Heidelberg AöRHeidelberg, NémetországNo longer taking part
- Klinikum der Universitaet Muenchen AöRMunich, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boehringer Ingelheim International GmbH
- Trial code
- EU 2023-508998-85-00
- Record updated
- 2024. december 20.